Quantitative proteomic analysis of residual host cell protein retention across adeno-associated virus affinity chromatography
- PMID: 39691383
- PMCID: PMC11650319
- DOI: 10.1016/j.omtm.2024.101383
Quantitative proteomic analysis of residual host cell protein retention across adeno-associated virus affinity chromatography
Abstract
To better understand host cell protein (HCP) retention in adeno-associated virus (AAV) downstream processes, sequential window acquisition of all theoretical fragment ion mass spectra (SWATH-MS) was used to quantitatively profile residual HCPs for four AAV serotypes (AAV2, -5, -8, and -9) produced with HEK293 cells and purified using POROS CaptureSelect AAVX affinity chromatography. A broad range of residual HCPs were detected in affinity eluates after purification (N total = 2,746), and HCP profiles showed universally present species (N universal = 1,117) and species unique to one or more AAV serotype. SWATH-MS revealed that HCP persistence was dominated by high-abundance conserved species (HACS), which appeared across all serotype conditions studied. Due to the notable contribution of these species to overall residual HCP levels, physical and functional characteristics of HACS were examined to determine trends that coincide with persistence. Subnetwork interaction mapping and Gene Ontology function enrichment analysis revealed extensive physical interactions between these proteins and significant enrichment for biological processes, molecular functions, and reactome pathways related to protein folding, nucleic acid binding, and cellular stress. The abundant and conserved nature of these HCPs and their functions offers a new perspective for mechanistic evaluations of impurity retention for AAV downstream processes.
Keywords: AAV; AAVX affinity chromatography; HCP; LC-MS/MS; adeno-associated virus; host cell protein; liquid chromatography-tandem mass spectrometry; proteomics.
© 2024 The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
A comparison of SWATH-MS methods for measurement of residual host cell proteins in adeno-associated virus preparations.Front Bioeng Biotechnol. 2025 May 2;13:1579098. doi: 10.3389/fbioe.2025.1579098. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40386465 Free PMC article.
-
High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography.Mol Ther Methods Clin Dev. 2022 Dec 16;28:146-159. doi: 10.1016/j.omtm.2022.12.009. eCollection 2023 Mar 9. Mol Ther Methods Clin Dev. 2022. PMID: 36654797 Free PMC article.
-
A simple and sensitive differential digestion method to analyze adeno-associated virus residual host cell proteins by LC-MS.J Pharm Biomed Anal. 2024 May 15;242:116009. doi: 10.1016/j.jpba.2024.116009. Epub 2024 Feb 6. J Pharm Biomed Anal. 2024. PMID: 38354541
-
In-Depth Host Cell Protein Analysis and Viral Protein Impurity Monitoring in Adeno-Associated Virus-Based Gene Therapy Products Using Optimized Wide Window Data-Dependent Acquisition Method.Anal Chem. 2024 Sep 12. doi: 10.1021/acs.analchem.4c02400. Online ahead of print. Anal Chem. 2024. PMID: 39263887
-
Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development.MAbs. 2023 Jan-Dec;15(1):2213365. doi: 10.1080/19420862.2023.2213365. MAbs. 2023. PMID: 37218066 Free PMC article. Review.
Cited by
-
A comparison of SWATH-MS methods for measurement of residual host cell proteins in adeno-associated virus preparations.Front Bioeng Biotechnol. 2025 May 2;13:1579098. doi: 10.3389/fbioe.2025.1579098. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40386465 Free PMC article.
-
Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing.Biotechnol Bioeng. 2025 Jul;122(7):1640-1655. doi: 10.1002/bit.28980. Epub 2025 Apr 8. Biotechnol Bioeng. 2025. PMID: 40197832 Free PMC article.
-
Investigating the Immunogenic Potential of Variations in Host Cell Protein Levels in Clinical-Grade AAV8 Products.Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):38. doi: 10.1167/iovs.66.6.38. Invest Ophthalmol Vis Sci. 2025. PMID: 40498045 Free PMC article.
-
Advancing AAV technology: From capsid design to scalable manufacturing.Mol Ther Methods Clin Dev. 2025 May 7;33(2):101477. doi: 10.1016/j.omtm.2025.101477. eCollection 2025 Jun 12. Mol Ther Methods Clin Dev. 2025. PMID: 40469752 Free PMC article. No abstract available.
References
-
- Clinicaltrials.gov (accessed November 8, 2023).
-
- Dobrowsky T., Gianni D., Pieracci J., Suh J. AAV manufacturing for clinical use: Insights on current challenges from the upstream process. Current Opinion in Biomedical Engineering. 2021;20 doi: 10.1016/j.cobme.2021.100353. - DOI
-
- Zhao H., Lee K.J., Daris M., Lin Y., Wolfe T., Sheng J., Plewa C., Wang S., Meisen W.H. Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach. Mol. Ther. Methods Clin. Dev. 2020;18:312–320. doi: 10.1016/j.omtm.2020.06.004. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous